Patents by Inventor Hyoungrok Paik

Hyoungrok Paik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for prevention and treatment of infection
    Patent number: 9540616
    Abstract: The present invention relates to a composition comprising bacteriophage SP-1, the bacteriophage capable of destroying Salmonella once being infected in Salmonella, as an active ingredient, and a method for prevention and treatment of Salmonella infection using the same. Bacteriophage SP-1, the active ingredient of the composition of the present invention, characteristically has the killing activity to Salmonella and has the genome represented by SEQ. ID. NO: 1.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: January 10, 2017
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seong Jun Yoon, Sooyoun Jun, Hyoungrok Paik, Gimo Jung, Yoonsik Shin, Sanghyeon Kang
  • METHOD FOR PREVENTION AND TREATMENT OF SALMONELLA INFECTION
    Publication number: 20160053234
    Abstract: The present invention relates to a composition comprising bacteriophage SP-1, the bacteriophage capable of destroying Salmonella once being infected in Salmonella, as an active ingredient, and a method for prevention and treatment of Salmonella infection using the same. Bacteriophage SP-1, the active ingredient of the composition of the present invention, characteristically has the killing activity to Salmonella and has the genome represented by SEQ. ID. NO: 1.
    Type: Application
    Filed: November 6, 2015
    Publication date: February 25, 2016
    Inventors: Seong Jun Yoon, Sooyoun Jun, Hyoungrok Paik, Gimo Jung, Yoonsik Shin, Sanghyeon Kang
  • Method for treatment of type K99 infections
    Patent number: 9211309
    Abstract: The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting E. coli type K99 so as to kill the same, as an active ingredient, and a method for preventing and treating E. coli type K99 infections using the said composition. According to the present invention, the bacteriophage EK99P-1, an active ingredient of the composition, has a killing activity against E. coli type K99 and has the genome represented by SEQ. ID. NO: 1.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: December 15, 2015
    Assignee: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seongjun Yoon, Sooyoun Jun, Hyoungrok Paik, Jeesoo Son, Sanghyeon Kang
  • Method for prevention and treatment of Escherichia coli type K99 infections
    Publication number: 20150004141
    Abstract: The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting E. coli type K99 so as to kill the same, as an active ingredient, and a method for preventing and treating E. coli type K99 infections using the said composition. According to the present invention, the bacteriophage EK99P-1, an active ingredient of the composition, has a killing activity against E. coli type K99 and has the genome represented by SEQ. ID. NO: 1.
    Type: Application
    Filed: June 26, 2014
    Publication date: January 1, 2015
    Inventors: Seongjun YOON, Sooyoun JUN, Hyoungrok PAIK, Jeesoo SON, Sanghyeon KANG
  • Method for Prevention and Treatment of Salmonella Infection
    Publication number: 20130011369
    Abstract: The present invention relates to a composition comprising bacteriophage SP-1, the bacteriophage capable of destroying Salmonella once being infected in Salmonella, as an active ingredient, and a method for prevention and treatment of Salmonella infection using the same. Bacteriophage SP-1, the active ingredient of the composition of the present invention, characteristically has the killing activity to Salmonella and has the genome represented by SEQ. ID. NO: 1.
    Type: Application
    Filed: July 5, 2011
    Publication date: January 10, 2013
    Applicant: INTRON BIOTECHNOLOGY, INC.
    Inventors: Seongjun Yoon, Sooyoun Jun, Hyoungrok Paik, Gimo Jung, Yoonsik Shin, Sanghyeon Kang
  • Lysin protein having broad antibacterial activity specific to bacteria
    Patent number: 8066990
    Abstract: The present invention relates to a lysin protein originated from bacteriophage, more precisely a lysin protein comprising the amino acid sequence represented by SEQ. ID. NO: 2 which has no harm to human and animals comprising eukaryotic cells owing to its specificity to bacteria and has broad antibacterial activity, and a pharmaceutical composition for the prevention and treatment of infectious disease caused by bacteria comprising the said lysin protein as an active ingredient.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: November 29, 2011
    Assignee: Intron Biotechnology, Inc.
    Inventors: Seongjun Yoon, Yunjaie Choi, Jeesoo Son, Sooyoun Jun, Hyoungrok Paik, Sanghyeon Kang
  • NOVEL LYSIN PROTEIN HAVING BROAD ANTIBACTERIAL ACTIVITY SPECIFIC TO BACTERIA
    Publication number: 20100172918
    Abstract: The present invention relates to a lysin protein originated from bacteriophage, more precisely a lysin protein comprising the amino acid sequence represented by SEQ. ID. NO: 2 which has no harm to human and animals comprising eukaryotic cells owing to its specificity to bacteria and has broad antibacterial activity, and a pharmaceutical composition for the prevention and treatment of infectious disease caused by bacteria comprising the said lysin protein as an active ingredient.
    Type: Application
    Filed: April 14, 2009
    Publication date: July 8, 2010
    Applicant: iNtRON Biotechnology, Inc.
    Inventors: SEONGJUN YOON, YUNJAIE CHOI, JEESOO SON, SOOYOUN JUN, HYOUNGROK PAIK, SANGHYEON KANG